Vector Science and Therapeutics Corp. (formerly OpenSesame Acquisition Corp.) News Releases

Vector Science and Therapeutics Corp. Issues Options

Fri, 25 Sep 2026 17:52:00 -0400

Mequon, Wisconsin--(Newsfile Corp. - September 25, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors has approved the grant of 150,000 stock options (the "Options") to an Officer of the Company in accordance with the Company's stock option plan. The Options vest in 25% tranches over a three year period, have an exercise price of C$1.80 and are exercisable for a period of five years from the date of grant. This...

Vector Science and Therapeutics Announces Listing on the TSX Venture Exchange

Fri, 24 Apr 2026 13:02:00 -0400

Canadian Public Market Listing Positions Vector Science and Therapeutics to Advance Biomechanical and Localized Drug Delivery Innovation Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) (formerly OpenSesame Acquisition Corp.) ("Vector" or the "Company") is pleased to announce the completion of its previously announced qualifying transaction (the "Qualifying Transaction") under Policy 2.4 - Capital Pool Companies of the TSX...